Protagonist Therapeutics (PTGX) Net Margin Growth (1y) (2018 - 2026)
Protagonist Therapeutics (PTGX) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 680.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Protagonist Therapeutics | 8.88 Bn | 8.88 Bn | - | 4,786.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,786.00 |
| Dec 31, 2025 | -67,657.00 |
| Sep 30, 2025 | -12,449.00 |
| Jun 30, 2025 | 10,669.00 |
| Mar 31, 2025 | -12,249.00 |
| Dec 31, 2024 | -806.00 |
| Jun 30, 2022 | -360,445.00 |
| Mar 31, 2022 | 12,750.00 |
| Dec 31, 2021 | -9,404.00 |
| Sep 30, 2021 | -26,944.00 |
| Jun 30, 2021 | -104,976.00 |
| Mar 31, 2021 | 16,284.00 |
| Dec 31, 2020 | -86,125.00 |
| Sep 30, 2020 | 33,711.00 |
| Jun 30, 2020 | 5,080.00 |
| Mar 31, 2020 | 35,345.00 |
| Dec 31, 2019 | 102,222.00 |
| Sep 30, 2019 | -25,351.00 |
| Jun 30, 2019 | -28,851.00 |
| Mar 31, 2019 | -83,298.00 |